ProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker Compound
August 03, 2023 08:00 ET
|
ProPhase Labs, Inc.
Garden City, NY, Aug. 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next generation biotech, genomics, therapeutics and diagnostics company, today provided an...